AXD2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heron Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.281 EUR -31.53% Market Closed

Market Cap: €69.6m

H	Heron Therapeutics Inc SWB:AXD2	US
	Black Box Entertainment Ltd OTC:BBOE	US
C	Cauldron Energy Ltd F:UFX	AU
G	Great Lakes Dredge & Dock Corp F:5GL	US
I	Integer Holdings Corp NYSE:ITGR	US
S	Sekisui Jushi Corp TSE:4212	JP
T	Taiming Assurance Broker Co Ltd TPEX:5878	TW
	Bukaka Teknik Utama Tbk PT IDX:BUKK	ID
	Capstone Therapeutics Corp OTC:CAPS	US
	ImageWare Systems Inc OTC:IWSY	US

Profitability Summary

Heron Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

45% > 70%

Negative Operating Margin

-15%

Negative 3Y Average Operating Margin

-28%

Operating Margin is Increasing

-117% > -15%

Negative Net Margin

-23%

Negative 3Y Average Net Margin

-32%

Net Margin is Increasing

-116% > -23%

Negative Free Cash Flow Margin

-8%

Negative 3Y Average Free Cash Flow Margin

-25%

Free Cash Flow Margin is Increasing

-108% > -8%

Exceptional ROE

335%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-24%

ROIC is Increasing

-88% > -12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.